Effects of Rikkunshito on postgastrectomy weight loss and nutritional status in gastric cancer patients: A retrospective observational study
Authors:
- Kenichi IwasakiKIKenichi Iwasaki
- Edward BarrogaEBEdward Barroga
- Yuki TakanoYTYuki Takano
- Toru SakuraiTSToru Sakurai
- Erika YamadaEYErika Yamada
- Masaya EnomotoMEMasaya Enomoto
- Yota ShimodaYSYota Shimoda
- Junichi MazakiJMJunichi Mazaki
- Hiroyuki KogaHKHiroyuki Koga
- Akishige KanazawaAKAkishige Kanazawa
- Yuichi NagakawaYNYuichi Nagakawa
Open Access
- 15 August 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43950
Abstract
Postgastrectomy disorders decrease the quality of life of patients because of poor oral intake and nutritional status. Rikkunshito is a Japanese herbal medicine that alleviates anorexia and prevents upper gastrointestinal disorders, particularly in the perioperative period. Herein, we investigated whether Rikkunshito administration in the early perioperative period alleviates weight loss and improves the nutritional status after undergoing minimally invasive distal gastrectomy for gastric cancer. We conducted a retrospective cohort study involving 139 consecutive gastric cancer patients who underwent laparoscopic or robot-assisted distal gastrectomy for potentially curable gastric cancer between January 2018 and May 2023 at our institution. We divided the patients into 2 groups based on Rikkunshito administration time: Rikkunshito administered on postoperative day 4 (RPOD4 group) and on postoperative day 1 (RPOD1 group). We performed one-to-one propensity score matching to balance the baseline characteristics. We examined the postoperative body weight changes and nutritional status at 1 month. One month postoperatively, the RPOD1 group showed a significantly smaller body weight change rate (7.12% [RPOD4] vs 5.35% [RPOD1], P < .05). For nutritional status, the RPOD1 group showed significantly higher prognostic nutritional index score (47.21 ± 16.45 [RPOD4] vs 49.45 ± 5.50 [RPOD1], P < .05) and geriatric nutritional risk index score (97.22 ± 20.49 [RPOD4] vs 100.97 ± 7.96 [RPOD1], P < .05). Initiating rikkunshito in the early perioperative period alleviates weight loss and improves the nutritional status after minimal invasive distal gastrectomy for gastric cancer.Keywords
This publication has 36 references indexed in Scilit:
- Effect of Rikkunshito, a Chinese Herbal Medicine, on Stasis in Patients After Pylorus‐Preserving GastrectomyWorld Journal of Surgery, 2008
- Rikkunshito, an Herbal Medicine, Suppresses Cisplatin-Induced Anorexia in Rats Via 5-HT2 Receptor AntagonismGastroenterology, 2008
- A Multicenter Study on Oncologic Outcome of Laparoscopic Gastrectomy for Early Cancer in JapanAnnals of Surgery, 2007
- Enhanced recovery after surgery: A consensus review of clinical care for patients undergoing colonic resectionClinical Nutrition, 2005
- Effects of Rikkunshi-to, a Traditional Japanese Medicine, on the Delay of Gastric Emptying Induced by NG-Nitro-L-arginineJournal of Pharmacological Sciences, 2005
- The herbal medicine Rikkunshi-to stimulates and coordinates the gastric myoelectric activity in post-operative dyspeptic children after gastrointestinal surgeryPediatric Surgery International, 2004
- Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients.2002
- New trends in surgery for gastric cancer in JapanJournal of Surgical Oncology, 1994
- Effect of treatment with Liu‐Jun‐Zi‐Tang (TJ‐43) on gastric emptying and gastrointestinal symptoms in dyspeptic patientsAlimentary Pharmacology & Therapeutics, 1993
- Surgical strategy for early gastric cancerBritish Journal of Surgery, 1990